Trigeminal Neuralgia

Populations and Risk Factors

Peak onset between ages 50 and 70; rare before age 40 (early onset raises suspicion for MS)
Women affected slightly more than men (approximately 1.5:1)
Right side affected approximately 5 times more frequently than left — anatomical theories suggest the right-sided predominance may relate to narrower foramina on the dominant side, though the mechanism is debated
Multiple sclerosis: 2–5% of MS patients develop TN (demyelinating plaques at the trigeminal root entry zone); TN may be the presenting symptom of MS in young patients
Hypertension and atherosclerosis increase risk — vascular changes may contribute to compression at the nerve root entry zone
Almost always unilateral; bilateral TN is rare (<3%) and strongly associated with MS

Causes and Pathophysiology

CN V Anatomy

The trigeminal nerve (CN V) is the largest cranial nerve and is both sensory and motor. Its anatomy explains the clinical pattern of trigeminal neuralgia:

Sensory root: Three divisions emerge from the trigeminal ganglion (Gasserian ganglion) in Meckel's cave on the petrous apex of the temporal bone:
V1 (ophthalmic): forehead, upper eyelid, conjunctiva, bridge of nose, frontal and ethmoidal sinuses — exits through the superior orbital fissure
V2 (maxillary): cheek, upper lip, upper teeth and gingiva, nasal cavity, palate, maxillary sinus, lower eyelid — exits through the foramen rotundum
V3 (mandibular): lower face, lower lip, lower teeth and gingiva, anterior two-thirds of the tongue (general sensation only — taste is CN VII), chin, temporal region, external ear — exits through the foramen ovale
Motor root: Travels with V3 only; innervates the muscles of mastication (masseter, temporalis, medial and lateral pterygoids, mylohyoid, anterior digastric). Motor function is typically preserved in TN — the pathology affects sensory fibers
Brainstem nuclei: The trigeminal nerve connects to four nuclei: the mesencephalic nucleus (proprioception from jaw muscles — mediates the jaw jerk reflex), the principal sensory nucleus (discriminative touch), and the spinal trigeminal nucleus (pain and temperature — extends inferiorly to merge with the dorsal horn at C2–C3, forming the trigeminocervical nucleus). The motor nucleus innervates the muscles of mastication via V3

Vascular Compression Mechanism (Primary TN)

The primary cause of classic TN is neurovascular compression at the nerve root entry zone (REZ) — the transition zone where central (oligodendrocyte) myelin transitions to peripheral (Schwann cell) myelin, approximately 2–4 mm from the pons:

The superior cerebellar artery (SCA) is the most common compressing vessel (75–80% of surgical cases), though the anterior inferior cerebellar artery or venous structures may also be involved
Chronic pulsatile compression against the nerve root causes focal demyelination at the REZ — the myelin sheath is progressively worn away, exposing bare axons
Demyelinated axons come into close physical contact, enabling ephaptic transmission — electrical cross-talk between adjacent fibers where action potentials jump from one axon to another without a synaptic connection
In ephaptic transmission, activation of large-diameter, low-threshold mechanoreceptor fibers (A-beta fibers — which normally carry light touch) cross-activates adjacent small-diameter nociceptive fibers (A-delta and C fibers). This is why a non-painful stimulus such as a light breeze or touching the cheek triggers excruciating pain — the touch signal literally misfires into pain pathways at the point of demyelination

Why the Pain Is Paroxysmal

The ephaptic discharge is triggered by low-threshold mechanoreceptor input arriving at the demyelinated zone — this explains why specific trigger zones exist (the area of facial skin whose sensory fibers pass through the demyelinated segment)
Once an ephaptic discharge fires, it produces a burst of high-frequency action potentials that is experienced as a sudden, intense shock of pain lasting seconds to two minutes
After the burst, the demyelinated segment enters a refractory period — the axons are temporarily inexcitable, which produces the characteristic pain-free interval between attacks. During this refractory window, even stimulating the trigger zone will not provoke pain
This cycle of trigger-burst-refractory period is the defining temporal signature of Type 1 (classic) TN and distinguishes it from constant neuropathic pain conditions

Secondary TN

In secondary TN, demyelination at the trigeminal nerve root is caused by an identifiable structural lesion rather than vascular compression:

Multiple sclerosis: Demyelinating plaques at the REZ produce the same ephaptic transmission mechanism; TN in a patient under 40 should raise suspicion for MS
Tumors: Cerebellopontine angle tumors (acoustic neuromas, meningiomas, epidermoid cysts) may compress the nerve root
Bone spurs or Paget's disease: Bony overgrowth may impinge on the nerve as it exits its foramina
Post-surgical or post-traumatic: Dental procedures, facial surgery, or trauma may damage trigeminal nerve branches
Key distinguishing sign: Secondary TN often produces sensory deficit (numbness, hypoesthesia) in the affected distribution — classic primary TN does not. Preserved normal sensation between attacks is characteristic of primary TN

Central Sensitization in Chronic TN

With prolonged or frequent paroxysms, the trigeminal nucleus caudalis (spinal trigeminal nucleus) undergoes central sensitization — neuronal hyperexcitability amplifies and sustains pain signaling
Central sensitization may explain the transition from Type 1 (purely paroxysmal) to Type 2 (constant background ache with superimposed paroxysms) in some patients
This has treatment implications: once central sensitization is established, peripheral interventions alone may be less effective, and pharmacological management becomes more critical

Signs and Symptoms

Type 1 (Classic) TN

Sudden, sharp, stabbing, electric shock-like pain — patients describe it as "lightning-like" or "like a knife"
Pain lasts 10 seconds to 2 minutes per paroxysm; occurs in clusters of multiple paroxysms throughout the day
Pain-free intervals between paroxysms (refractory period)
Specific trigger zones on the face — areas where light touch, cold air, chewing, speaking, or washing the face provokes an attack
Facial tic (involuntary grimace or flinch) during the paroxysm — the origin of the historical name tic douloureux ("painful tic")
Unilateral; right side in approximately 80% of cases
Normal facial sensation preserved between attacks — no numbness, no weakness
V2 (maxillary) and V3 (mandibular) are the most commonly affected divisions; V1 (ophthalmic) alone is least common
Pain intensity is extreme — frequently described as the worst pain the patient has ever experienced

Type 2 (Atypical) TN

Constant, dull, aching, burning background pain in the affected trigeminal distribution
Superimposed paroxysms of sharp, shock-like pain (similar to Type 1) on top of the constant ache
Less defined trigger zones; trigger stimuli less consistent
Refractory period less distinct — pain does not fully resolve between paroxysms
More difficult to treat; suggests central sensitization or secondary pathology
Numbness or sensory deficit in the affected area raises concern for secondary TN and warrants neurological referral

Distribution by Branch

Branch	Territory	Common Triggers in That Territory
V1 (ophthalmic)	Forehead, upper eyelid, bridge of nose	Wind on forehead, touching eyebrow area
V2 (maxillary)	Cheek, upper lip, upper teeth, nose	Touching cheek, brushing teeth, shaving upper lip, cold air
V3 (mandibular)	Lower face, lower lip, lower teeth, chin, jaw	Chewing, speaking, brushing lower teeth, touching chin
V2+V3 combined	Most common combined pattern	Any of the above; may initially present in one division then spread

Assessment Profile

Subjective Presentation

Chief complaint: Sudden, severe, electric shock-like pain on one side of the face; patient often points precisely to the affected area; may report being afraid to eat, talk, brush teeth, or wash their face; describes between-attack periods of dread
Pain quality: Sharp, stabbing, electric shock-like, "lightning bolt" — brief (seconds to two minutes per paroxysm); if constant background ache is present, ask specifically about superimposed sharp episodes to differentiate Type 1 from Type 2; the pain is often described as the most intense the patient has ever experienced
Onset: Spontaneous onset, often without identifiable initial cause; may follow dental work (secondary TN) or develop gradually with increasing frequency of paroxysms; ask about age at first episode (onset before age 40 raises suspicion for MS)
Aggravating factors: Light touch to specific facial trigger zones (not deep pressure); chewing (especially hard foods); brushing teeth; cold breeze or wind on the face; speaking; shaving; washing or drying the face; applying makeup; drinking cold liquids
Easing factors: Pain resolves spontaneously after seconds to minutes (refractory period); carbamazepine (first-line pharmacological treatment) reduces paroxysm frequency and severity; warmth may help prevent cold-triggered episodes; some patients identify a "safe" pressure that does not trigger (firm sustained pressure vs. light touch)
Red flags: New onset of numbness or sensory loss in the affected trigeminal distribution (suggests secondary TN — tumor, MS); bilateral TN (strongly associated with MS); progressive motor weakness in muscles of mastication; onset under age 40 → neurological referral required to rule out MS or structural lesion

Observation

Local inspection: During a paroxysm: involuntary facial tic or grimace on the affected side (tic douloureux); tearing of the ipsilateral eye possible; between attacks, facial appearance is typically normal; with chronic V3 involvement, mild masseter or temporalis atrophy may be visible from disuse (patient avoids chewing on the affected side); note any protective hand positioning (patient shielding the face)
Posture: Protective head posture — patient may tilt head to shield the affected side from drafts or accidental contact; cervical guarding and suboccipital tension secondary to chronic pain and anxiety; forward head posture may develop from chronic protective positioning
Gait: Not clinically relevant to this condition

Palpation

Palpation of the facial trigger zones must be approached with extreme care. Explain the purpose before touching, begin with firm sustained contact rather than light touch (light touch is more likely to trigger a paroxysm than firm pressure), and have the patient identify their known trigger zones before palpation begins. During an active episode, defer facial palpation entirely.

Tone: Cervical and suboccipital hypertonicity — secondary to chronic pain guarding and protective posturing; typically bilateral but more pronounced ipsilateral to the affected side; upper trapezius, SCM, levator scapulae tension from sustained guarding posture; if V3 is involved, masseter and temporalis may show protective hypertonicity from guarded jaw clenching, or alternatively may show reduced tone from disuse if the patient avoids chewing on that side — compare bilaterally
Tenderness: Trigger zone mapping — specific points on the face where light touch provokes a paroxysm; most commonly along V2 (nasolabial fold, cheek, upper lip) and V3 (chin, lower lip, jaw angle); trigeminal nerve branch palpation: supraorbital notch (V1), infraorbital foramen (V2), mental foramen (V3) — tenderness at these points localizes the affected division; suboccipital attachments at occiput (C0–C1 junction) characteristically tender as a secondary finding from chronic guarding; cervical articular pillars (C1–C3) — tenderness here reflects cervical contribution to the pain state via the trigeminocervical nucleus (same convergence mechanism as in migraine); compare bilateral findings to identify asymmetry
Temperature: Usually normal; no inflammatory component in primary TN; coolness on the affected side of the face would suggest vascular compromise and warrants referral
Tissue quality: Suboccipital muscles commonly fibrotic and nodular from chronic tension; TrPs in upper trapezius and SCM consistent with sustained guarding pattern; masseter may show fibrotic changes or TrPs if V3 involvement has caused chronic jaw clenching; reduced fascial mobility through the cervico-cranial region; cervical intersegmental mobility may be restricted at C0–C2 secondary to chronic suboccipital guarding

Motion Assessment

AROM: Cervical AROM may be mildly restricted — particularly rotation and lateral flexion to the affected side — secondary to chronic guarding; this is a secondary musculoskeletal finding, not a primary feature of TN; if V3 is involved, jaw opening may be restricted from masticatory muscle guarding; ask the patient to open the mouth fully and note deviation (deviation toward the restricted side suggests unilateral pterygoid guarding)
PROM / end-feel: Cervical passive range typically near-normal with guarded or muscle-spasm end-feel — consistent with protective guarding rather than structural restriction; jaw PROM (if V3): gentle overpressure may reveal increased range compared to AROM, confirming muscular guarding rather than joint pathology
Resisted testing: Cervical resisted testing normal; jaw resisted testing (clench against resistance) typically normal in primary TN — motor root is spared; any true motor weakness in mastication muscles suggests secondary TN with motor root involvement and requires referral

Special Test Cluster

TN is a clinical diagnosis confirmed by history and trigger zone identification. The SOT cluster is oriented toward differential diagnosis, red flag exclusion, and localizing the affected branch — there is no single special test that confirms TN.

Test	Positive Finding	Purpose
CN V sensory testing (CMTO)	Intact light touch and pinprick sensation in all three divisions between attacks (primary TN); reduced sensation or numbness in the affected division (secondary TN)	Differentiate primary TN (sensation preserved) from secondary TN (sensory deficit present); localize the affected branch
Jaw jerk reflex (CMTO)	Normal or mildly brisk — confirms intact trigeminal motor and sensory arc; hyperactive jaw jerk raises suspicion for UMN lesion	Assess trigeminal motor integrity; screen for central nervous system pathology
Corneal reflex (supplementary)	Normal blink response bilaterally; absent or diminished reflex on the affected side suggests V1 involvement or brainstem pathology	Test V1 afferent and CN VII efferent arc; absent reflex with facial numbness raises concern for cerebellopontine angle lesion
Cervical AROM (CMTO — rule out)	Normal or mildly restricted from guarding; reproduction of facial pain with cervical movement would suggest cervicogenic face pain rather than TN	Rule out cervicogenic facial pain; cervical movement should not reproduce trigeminal paroxysms
FAST screen (CMTO — rule out)	Negative — no facial droop (CN VII), arm drift, speech difficulty, or acute onset	Rule out stroke or transient ischemic attack presenting with facial symptoms

Conditional cluster: If the patient is under 40 or presents with bilateral symptoms, numbness, or progressive motor weakness, add Lhermitte's sign testing and refer for neurological investigation to rule out MS.

Differential Diagnoses

Condition	Key Distinguishing Feature
Dental pathology	Pain localized to a specific tooth; provoked by biting or thermal stimulus on the tooth; dental examination reveals caries, abscess, or cracked tooth; no trigger zones on facial skin
Temporomandibular joint syndrome	Dull ache localized to TMJ and temporal region; clicking or crepitus on jaw opening; pain on palpation of TMJ; associated with jaw clenching or bruxism; no paroxysmal shock-like quality
Cluster headache	Strictly periorbital; autonomic features (ptosis, lacrimation, rhinorrhea, conjunctival injection); 15–180 min duration; circadian/seasonal pattern; male-predominant
Post-herpetic neuralgia	History of herpes zoster (shingles) in the affected dermatome; visible scarring from prior vesicular rash; constant burning pain rather than paroxysmal shocks; V1 most commonly affected
Multiple sclerosis with TN	Onset under age 40; bilateral TN; sensory deficit (numbness) in the affected division; other neurological signs (optic neuritis, Lhermitte's, limb weakness); neurological referral required

CMTO Exam Relevance

Classified as A4 neurological condition; commonly tested as a differential diagnosis alongside cluster headache, migraine, and tension headache
Key exam distinction: TN pain is triggered by innocuous stimuli (light touch, cold) — this allodynia-like mechanism (ephaptic transmission, not central sensitization) is unique to TN among facial pain conditions
Know the three divisions of CN V and their territories — exam questions frequently test which branch is affected based on the pain distribution described
Sensation preserved in primary TN — numbness indicates secondary TN; this is a consistently tested distinction
Carbamazepine (antiseizure medication) is the first-line pharmacological treatment — standard analgesics (NSAIDs, acetaminophen, opioids) are ineffective; exam questions test this pharmacological distinction
Medication masking: antiseizure medications (carbamazepine, oxcarbazepine, gabapentin) alter pain perception threshold; the patient's pain presentation during treatment may not reflect their true pain state; adjust treatment accordingly
Know the jaw jerk reflex (CN V afferent and efferent — both trigeminal) and corneal reflex (CN V afferent, CN VII efferent) as testable cranial nerve assessments

Massage Therapy Considerations

Primary therapeutic target: Cervical and suboccipital musculature — secondary tension from chronic pain guarding and protective posturing is the primary structure MT addresses. MT does not treat the trigeminal nerve directly. The neuroanatomical rationale is the same as in migraine prophylaxis: reducing cervical input to the trigeminocervical nucleus (where C1–C3 and CN V sensory fibers converge) may modulate trigeminal sensitization
Sequencing logic: Begin with cervical and upper back work to address the secondary musculoskeletal consequences of chronic pain; progress to suboccipital release; facial and jaw work is conditional on trigger zone mapping and current symptom state — only approach these regions if the patient is in a stable inter-attack period and trigger zones have been clearly identified and avoided
Safety / contraindications:
Facial and head massage is contraindicated during an acute flare (active paroxysms occurring frequently) — any tactile stimulus to the face risks triggering a paroxysm
Trigger zones must be identified before treatment and strictly avoided — even gentle contact can provoke severe pain
Light touch to the face is more provocative than firm sustained pressure (ephaptic transmission is triggered by mechanoreceptor input, which is activated by light touch more than deep pressure) — if facial work is attempted in a stable period, use firm sustained contact rather than light stroking
Face cradle pressure: direct pressure of a face cradle on V2/V3 trigger zones can provoke a paroxysm — use a side-lying or supine position for prone alternative
Environmental controls: avoid cold drafts from fans, air conditioning, or open windows — cold air on the face is a common trigger
Heat/cold guidance: Warm towel to the cervical and suboccipital region is appropriate and beneficial for tissue preparation; do not apply cold to the face (cold is a common trigger); avoid any temperature stimulus to identified trigger zones
Medication interaction: Carbamazepine and other antiseizure medications may cause dizziness, drowsiness, and coordination difficulties — assist client off table slowly; these medications mask the pain threshold, meaning the patient may not accurately report tissue discomfort during treatment; reduce treatment intensity accordingly

Treatment Plan Foundation

Clinical Goals

Reduce cervical and suboccipital hypertonic guarding secondary to chronic facial pain
Address masticatory muscle tension and TrPs (if V3 involved and trigger zones can be avoided)
Restore cervical ROM restricted by chronic protective posturing
Support parasympathetic down-regulation through low-stimulus, calming treatment environment

Position

Supine with cervical roll for suboccipital and cervical access — preferred starting position; allows the therapist to see the patient's face and monitor for pain response
Side-lying as alternative to prone — avoids face cradle pressure on trigger zones
Prone is contraindicated if face cradle contacts known trigger zones; if prone is essential for thoracic work, use a face opening that eliminates all contact with the cheek, upper lip, chin, and jaw areas, or position the patient with forehead support only

Session Sequence

General effleurage to upper trapezius and cervical region bilaterally — assess tissue state; establish a calm, low-stimulus treatment environment (dim lighting, no fans, quiet room)
Myofascial release to upper trapezius bilaterally — reduce superficial guarding; address the sustained tension pattern from chronic protective posturing
SCM release — sustained compression and gentle longitudinal stripping; bilateral but emphasize the ipsilateral side where guarding is more pronounced
Levator scapulae release — sustained compression at the superior angle of the scapula and along the muscle belly; address the shoulder-hiking component of the guarding pattern
Suboccipital release — slow, sustained compression into rectus capitis posterior major/minor and obliquus capitis superior/inferior at the occipital attachments; this is the primary treatment target; hold until tissue release is felt; do not rush or use aggressive depth
Temporalis and masseter release [only if V3 involved AND patient is in a stable inter-attack period AND trigger zones have been mapped and can be avoided] — firm, sustained compression (not light stroking); approach from the temporal region first (less likely to contact trigger zones); patient controls depth and reports any prodromal sensation immediately
Cervicothoracic junction work — address postural contribution from chronic forward head positioning; upper thoracic PA pressure and paraspinal stripping

Adjunct Modalities

Hydrotherapy: Warm towel to the cervical and suboccipital region pre-treatment to improve tissue pliability before deep suboccipital work; no hydrotherapy to the face — neither cold nor warm applications; avoid any temperature stimulus to facial trigger zones
Joint mobilization: C0–C2 segmental mobilization — gentle PA and rotational glide to restore intersegmental mobility after suboccipital soft tissue release; defer if the patient is experiencing frequent paroxysms (treatment session should focus on calming input, not mechanical challenge)
Remedial exercise (on-table): Gentle active cervical ROM through pain-free range after suboccipital release — assess for improved range as an outcome measure; if V3 involved and jaw opening is restricted from guarding, gentle active jaw opening within tolerance — patient-controlled, therapist does not provide overpressure

Exam Station Notes

Demonstrate trigger zone identification before any facial or head contact — ask the patient to identify and mark their known trigger zones
State the rationale for avoiding prone/face cradle positioning and demonstrate the alternative (supine or side-lying)
Show understanding that treatment targets the secondary musculoskeletal consequences (cervical guarding, suboccipital tension) — not the trigeminal nerve itself
Reassess cervical AROM and suboccipital tenderness post-treatment as outcome measures; do not reassess facial trigger zones (this risks triggering a paroxysm and provides no useful treatment outcome data)

Verbal Notes

Before treatment: "I want to map out any areas on your face where light touch triggers your pain, so I know exactly where to avoid. Can you show me those areas?" — document trigger zones; confirm environmental controls (no fans, drafts)
Face cradle: "I'm going to avoid using a face cradle today because the pressure on your face could trigger your symptoms. We'll use a side-lying or supine position instead."
Cervical work: "The work I'm doing on your neck and the base of your skull targets the muscle tension that builds up from coping with your facial pain. This doesn't treat the nerve directly, but it can help reduce the overall tension your body is carrying."
Medication awareness: "Your medication can affect how you feel pressure, so please let me know if anything feels uncomfortable — even if it seems minor."

Self-Care

Cervical and suboccipital self-release (tennis ball at occiput against wall) — reduces secondary tension buildup between treatment sessions
Jaw relaxation exercises (if V3 involved): gentle rhythmic jaw opening-closing within pain-free range; conscious unclenching throughout the day — many patients clench the jaw protectively without realizing it
Environmental modification: wear a scarf or face covering in cold or windy conditions to protect trigger zones from cold-air provocation; avoid direct fan airflow on the face during sleep
Stress management: paroxysm frequency often increases during periods of high stress; relaxation techniques (diaphragmatic breathing, progressive muscle relaxation) may help reduce the overall excitability of the trigeminal system

Key Takeaways

Trigeminal neuralgia produces paroxysmal, shock-like facial pain triggered by innocuous stimuli — the mechanism is ephaptic transmission at a focally demyelinated nerve root, not central sensitization
Primary TN preserves normal sensation between attacks; numbness or sensory deficit in the affected distribution suggests secondary TN (MS, tumor) and requires neurological referral
The right side is affected approximately 5 times more than the left; bilateral TN is rare and strongly associated with MS
CN V has three sensory divisions (V1 ophthalmic, V2 maxillary, V3 mandibular); V2 and V3 are the most commonly affected in TN
Standard analgesics are ineffective; carbamazepine (antiseizure medication) is the first-line pharmacological treatment — this is a consistently tested pharmacological distinction
MT treats the secondary musculoskeletal consequences (cervical guarding, suboccipital tension, masticatory muscle changes) — not the trigeminal nerve directly; facial massage is contraindicated during active flares
Trigger zones must be identified and avoided; light touch is more provocative than firm pressure; face cradle pressure and cold drafts are specific environmental hazards that must be controlled
The refractory period between paroxysms is a defining feature of Type 1 TN and distinguishes it from constant neuropathic pain conditions